Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Bravelle (Urofollitropin) Injection Purified
Company:  Femring Pharmaceuticals, Inc.
Application No.:  21-289
Approval Date: 5/6/2002


Date created: October 09, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.